Post-concussion and traumatic brain injury support
Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer
BPC-157, which is not approved for human use, is an experimental compound being tested to treat inflammatory bowel disease and soft tissue healing, according to the USADA
As a key part of the bodys endogenous defense mechanism, the presence of glutathione neutralizes and reduces these free radicals.* The production of ROS increases with age, at the same time our internal defense mechanisms weaken, resulting in oxidative stress an imbalance where ROS outnumber antioxidants in the body
From amino acid derivatives and building blocks through to large-scale commercial API, supported by deep analytical, quality and regulatory expertise
MILCOM helped identify SBIR projects and companies with high transition potential that met high-priority requirements, provided market research and business plan development, matched SBIR companies to customers and facilitated collaboration, prepared detailed technology transition plans and agreements, andnotablyprovided additional funding for select SBIR projects